Acute Myelogenous Leukemia (AML) - Adult
Alternate Names : Acute Granulocytic Leukemia, Acute Myeloid Leukemia (AML), Acute Nonlymphocytic Leukemia (ANLL)
DefinitionAcute myelogenous leukemia involves a malignancy (cancer) of blood-forming tissues of the bone marrow characterized by the proliferation of immature white blood cells. There are 8 categories of AML, categorized as M0 to M7, based on which blood cells are abnormal.
Pictures & Images
 See all Pictures & Images
Overview, Causes, & Risk Factors
Acute myelogenous leukemia (AML) may occur at any age, but it primarily affects adults and children younger than one year old. This discussion focuses on AML in adults. In this condition, certain blood cells of the immune system, which are grown in the bone marrow, lose their ability to mature and specialize (differentiate). These cells multiply rapidly and replace normal blood cells.
Bone marrow failure occurs as malignant cells replace normal bone marrow elements. The person becomes susceptible to bleeding and infection as the normal blood cells lose their ability to fight microorganisms and decrease in number.
Most cases have no apparent cause. However, radiation, some toxins such as benzene, and some chemotherapy agents (including etoposide and drugs known as alkylating agents) are thought to cause some kinds of leukemia, including AML. Genetic abnormalities may also play a role in the development of this condition.
Risk factors include the following:
The incidence is 2.5 out of 100,000 people.
|
